Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer’s disease

Overview of attention for article published in Acta Neuropathologica Communications, February 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 1 news outlet
twitter: 16 X users

patent: 3 patents

Citations

dimensions_citation: 65 Dimensions

Readers on

mendeley: 96 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

METHODS OF USING AN ANTI-AMYLOID BETA PROTOFIBRIL ANTIBODY AND ANTI-TAU ANTIBODY

Application WO-2023111618-A1

World Intellectual Property Organisation (WIPO)

METHODS OF USING AN ANTI-AMYLOID BETA PROTOFIBRIL ANTIBODY AND ANTI-TAU ANTIBODY

Application WO-2023114586-A1

World Intellectual Property Organisation (WIPO)

ANTI-TAU ANTIBODY COMPOSITIONS, DOSAGE FORMS, AND METHODS

Application WO-2023079485-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.